Proteomic markers of response to anti-TNF drugs in patients with Crohn's disease

被引：3
|
作者：
Medina-Medina, R. [1 ]
Iglesias-Flores, E. [1 ]
Benitez, J. M. [1 ]
Marin-Pedrosa, S. [1 ]
Salgueiro, I. [1 ]
Ferrin, G. [1 ]
Linares, C. I. [1 ]
Gonzalez-Rubio, S. [1 ]
Soto, P. [1 ]
Gros, B. [1 ]
Moral, C. [1 ]
Alvarez, F. [1 ]
Rodriguez-Peralvarez, M. [1 ]
Chicano-Galvez, E. [1 ]
Ortea, I. [1 ]
Garcia-Sanchez, V. [1 ]
Aguilar-Melero, P. [1 ]
机构：
[1] Cordoba Univ, Hosp Univ Reina Sofia, IMIBIC, Cordoba, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
10.1093/ecco-jcc/jjy222.132
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P008
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [1] Efficacy of anti-TNFα drugs in patients with stricturing Crohn's disease
    D'Amico, Ferdinando
    Pugliese, Nicola
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (05) : 347 - 353
  • [2] Serum proteomic analysis defines novel circulating inflammatory markers for Crohn's disease and response to anti-TNF therapy
    Korf, H.
    Sabino, J.
    Ballet, V.
    de Bruyn, M.
    Van Assche, G.
    Ferrante, M.
    Vermeire, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S56 - S57
  • [3] Loss of Anti-TNF Drugs Into Feces and Its Impact on Anti-TNF Serum Levels and Clinical Response in Crohn's Disease (CD) Patients
    Chaparro, Maria
    Guerra, Ivan
    Bujanda, Luis
    Nuno, Jose Luis Cabriada
    Taxonera, Carlos
    Marin-Jimenez, Ignacio
    Linares, Pablo M.
    Ramas, Mercedes
    Gisbert, Javier P.
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S421 - S421
  • [4] Molecular predictors of anti-TNF treatment response in patients with Crohn's disease
    Walczak, M.
    Lykowska-Szuber, L.
    Plucinska, M.
    Michalak, M.
    Krela-Kazmierczak, I.
    Zakerska-Banaszak, O.
    Stawczyk-Eder, K.
    Eder, P.
    Dobrowolska, A.
    Slomski, R.
    Skrzypczak-Zielinska, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S640 - S640
  • [5] Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agent
    del Carmen R-Grau, Maria
    Chaparro, Maria
    Mesonero, Francisco
    Barreiro-de Acosta, Manuel
    Castro, Luisa
    Castro, Manuel
    Domenech, Eugeni
    Mancenido, Noemi
    Lazaro Perez-Calle, Jose
    Taxonera, Carlos
    Barrio, Jesus
    De Francisco, Ruth
    Fernandez-Salgado, Estela
    Luzon, Lara
    Merino, Olga
    Oltra, Lorena
    Saro, Cristina
    Bermejo, Fernando
    Garcia-Sanchez, Valle
    Ginard, Daniel
    Gutierrez, Ana
    Vera, Isabel
    Anton, Rosario
    Ber, Yolanda
    Calvet, Xavier
    Gisbert, Javier P.
    [J]. DIGESTIVE AND LIVER DISEASE, 2016, 48 (06) : 613 - 619
  • [6] PROTEIN PROFILING OF CIRCULATING INFLAMMATORY MARKERS FOR CROHN'S DISEASE AND RESPONSE TO ANTI-TNF THERAPY
    Korf, Hannelie
    Sabino, Joao
    Ballet, Vera
    de Bruyn, Magali
    Van Assche, Gert A.
    Ferrante, Marc
    Vermiere, Severine
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S762 - S762
  • [7] Another anti-TNF therapy for patients with Crohn's disease
    Cross, Raymond
    [J]. INFLAMMATORY BOWEL DISEASES, 2008, 14 (03) : 425 - 427
  • [8] Anti-TNF therapy and Crohn's disease
    Peyrin-Biroulet, L.
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2008, 32 (05): : 478 - 481
  • [9] Anti-TNF Therapy in Crohn's Disease
    Adegbola, Samuel O.
    Sahnan, Kapil
    Warusavitarne, Janindra
    Hart, Ailsa
    Tozer, Philip
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (08)
  • [10] Anti-TNF treatment of Crohn's disease
    Camoglio, L
    VanDeventer, SJH
    Tytgat, GNJ
    [J]. TRENDS IN INFLAMMATORY BOWEL DISEASE THERAPY 1996, 1997, : 111 - 117
12345